Solstice Oncology
Solstice Oncology is a Healthcare & Life Sciences startup based in Boston, the United States, most recent round Series A, 1 tracked investor.
About Solstice Oncology
Solstice Oncology is a company headquartered in Boston, the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Solstice Oncology is a clinical-stage immuno-oncology company developing porustobart, a next-generation engineered CTLA-4 antibody used in combination with anti–PD-1 therapy to treat early-stage cancers, primarily microsatellite-stable stage III colon cancer, by intervening before surgery to improve cure rates.
Explore Solstice Oncology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.